Support Alert

Class 4 medicine defect information: zoledronic acid 5mg solution for infusion

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed the MHRA that some packs from a batch of zoledronic acid 5mg solution for infusion contain a patient information leaflet for temozolomide 180mg capsules.

Further information, affected batch details and advice for healthcare professionals can be found on the MHRA website.

Loading...

Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up